1 |
Bhimma R, Coovadia HM. Hepatitis B virus-associated nephropathy. Am J Nephrol 2004;24:198-211.
DOI
ScienceOn
|
2 |
Liao MT, Chang MH, Lin FG, Tsai IJ, Chang YW, Tsau YK. Universal hepatitis B vaccination reduces childhood hepatitis B virus-associated membranous nephropathy. Pediatrics 2011;128:e600-e604.
|
3 |
Lai KN, Li PK, Lui SF, et al. Membranous nephropathy related to hepatitis B virus in adults. N Engl J Med 1991;324:1457-1463.
DOI
ScienceOn
|
4 |
Yi Z, Jie YW, Nan Z. The efficacy of anti-viral therapy on hepatitis B virus-associated glomerulonephritis: a systematic review and meta-analysis. Ann Hepatol 2011;10:165-173.
|
5 |
Zheng XY, Wei RB, Tang L, Li P, Zheng XD. Meta-analysis of combined therapy for adult hepatitis B virus-associated glomerulonephritis. World J Gastroenterol 2012;18:821-832.
DOI
ScienceOn
|
6 |
Sun IO, Hong YA, Park HS, et al. Experience of anti-viral therapy in hepatitis B-associated membranous nephropathy, including lamivudine-resistant strains. Korean J Intern Med 2012;27:411-416.
DOI
ScienceOn
|
7 |
Chang TT, Gish RG, de Man R, et al. A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B. N Engl J Med 2006;354:1001-1010.
DOI
ScienceOn
|
8 |
Ebata S, Hashimoto S, Suzuki A, et al. A case of adefovir-induced membranous nephropathy related to hepatitis B caused by lamivudine-resistant virus after liver transplant due to Byler's disease. Clin Exp Nephrol 2012;16:805-810.
DOI
ScienceOn
|
9 |
Lai KN, Tam JS, Lin HJ, Lai FM. The therapeutic dilemma of the usage of corticosteroid in patients with membranous nephropathy and persistent hepatitis B virus surface antigenaemia. Nephron 1990;54:12-17.
DOI
|
10 |
Shin SK, Ryu DR, Hwang JH, et al. Comparison between lamivudine alone and lamivudine and steroid combination in treatment of nephrotic syndrome associated with hepatitis B. Korean J Nephrol 1999;18:550-559.
|